RxSight Inc. (RXST) Financial Statements (2024 and earlier)

Company Profile

Business Address 100 COLUMBIA STREET
ALISO VIEJO, CA 92656
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3851 - Ophthalmic Goods (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:105,800159,300
Cash and cash equivalents11,83424,361
Short-term investments93,968134,971
Other undisclosed cash, cash equivalents, and short-term investments(2)(32)
Receivables10,9564,862
Inventory, net of allowances, customer advances and progress billings14,8358,032
Inventory14,8358,032
Other undisclosed current assets2,9644,101
Total current assets:134,555176,295
Noncurrent Assets
Operating lease, right-of-use asset3,9434,284
Property, plant and equipment10,13811,217
Restricted cash and investments761811
Other noncurrent assets767114
Total noncurrent assets:15,60916,426
TOTAL ASSETS:150,164192,721
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities15,2679,548
Accounts payable2,5951,689
Accrued liabilities12,6727,859
Debt15220
Other undisclosed current liabilities1,8181,509
Total current liabilities:17,23711,077
Noncurrent Liabilities
Long-term debt and lease obligation433,642
Finance lease, liability4317
Liabilities, other than long-term debt, including:2,813 
Operating lease, liability2,8133,625
Other undisclosed liabilities, other than long-term debt  
Other undisclosed noncurrent liabilities40,16936,135
Total noncurrent liabilities:43,02543,402
Total liabilities:60,26254,479
Equity
Equity, attributable to parent89,902138,242
Common stock2827
Additional paid in capital636,001617,511
Accumulated other comprehensive loss(95)(20)
Accumulated deficit(546,032)(479,276)
Total equity:89,902138,242
TOTAL LIABILITIES AND EQUITY:150,164192,721

Income Statement (P&L) ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
Revenues49,00522,593
Cost of revenue
(Cost of Goods and Services Sold)
(27,677)(18,076)
Gross profit:21,3284,517
Operating expenses(84,646)(57,304)
Operating loss:(63,318)(52,787)
Interest and debt expense(4,946)(3,682)
Loss from continuing operations before equity method investments, income taxes:(68,264)(56,469)
Other undisclosed income from continuing operations before income taxes1,5177,789
Loss from continuing operations before income taxes:(66,747)(48,680)
Income tax expense(9)(8)
Loss from continuing operations:(66,756)(48,688)
Loss before gain (loss) on sale of properties:(48,688)
Net loss available to common stockholders, diluted:(66,756)(48,688)

Comprehensive Income ($ in thousands)

12/31/2023
12/31/2022
12/31/2021
Net loss:(66,756)(48,688)
Comprehensive loss:(66,756)(48,688)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(75)(17)
Comprehensive loss, net of tax, attributable to parent:(66,831)(48,705)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: